Moreover, ZNRF3 depletion abolished the inhibitory effect of RMRP knockdown on cell survival in TMZ-treated parental glioma cells (U251 and LN229) and TMZ-resistant glioma cells (U251/TMZ and LN229/TMZ) (Figs. 5D and E). This evidence concerns the gene ZNRF3 and central nervous system cancer.